CNTB Connect Biopharma Holdings Ltd
Company Analysis
Latest News
🟢 Connect Biopharma is trading 6% up in pre-market despite no new company-specific catalyst
Connect Biopharma is trading 6.31% up at $2.34, with no new company-specific catalyst identified for September 1, 2026. - The latest material update remains...
🟢 Connect Biopharma is trading 7.62% up in pre-market after no new company-specific catalyst was identified
Connect Biopharma is trading 7.62% up at $2.40 in pre-market after no new company-specific catalyst was identified for August 31, 2026. - Its latest material...
🟢 Connect Biopharma is trading 12% up today in pre-market ahead of September Seabreeze STAT results
Connect Biopharma is trading 11.85% up now at $2.61, with the move appearing consistent with stronger pre-market sentiment. - No new company-specific...
🟢 Connect Biopharma is trading 8.77% up today in pre-market — possibly ahead of September clinical readouts
Connect Biopharma is trading 8.77% higher at $2.66 in pre-market, possibly reflecting continued interest ahead of September clinical readouts, though the...
🟢 Connect Biopharma is trading 6% up today as biotech ETF XBI gains 2.06%
Connect Biopharma is trading 6.13% up at $2.44, with the move appearing primarily sector-driven. - Biotech ETF XBI is up 2.06% during regular trading, amid...
🟢 Connect Biopharma is trading 6.84% up in pre-market with no company-specific catalyst identified
Connect Biopharma is trading at $2.46, up 6.84% from its August 24, 2026 close of $2.30, possibly reflecting broader risk-on sentiment with the catalyst...
🟢 Connect Biopharma is trading 5.72% up today in after-hours trading with no clear catalyst identified
Connect Biopharma is trading 5.72% up now at $2.43 after closing at $2.30 on August 24, 2026; no new company-specific announcement, earnings release,...
🟢 Connect Biopharma is trading 9.6% up in pre-market
Connect Biopharma is trading 9.6% up at $2.50, though no confirmed company-specific catalyst was identified for August 21, 2026. - The latest material update...
🟢 Connect Biopharma is trading 9.6% up in pre-market with no confirmed company-specific catalyst
Connect Biopharma is trading 9.6% up at $2.50 after no confirmed company-specific catalyst was identified for August 21, 2026. - Its latest material update...
🟢 Connect Biopharma is trading 9.2% up in pre-market with no confirmed catalyst
Connect Biopharma is trading 9.2% up in pre-market at $2.49, with no confirmed catalyst identified. - It closed at $2.28 on August 20, 2026. - No new...
🔴 Connect Biopharma is trading 5.24% down today after broader biotech weakness
Connect Biopharma is trading 5.24% down at $2.33 after broader biotech weakness and profit-taking pressured the sector on August 20, 2026. - Biotech ETF XBI...
🟢 Connect Biopharma is trading 6.1% up today amid biopharma rally after positive melanoma vaccine results
Connect Biopharma is trading 6.1% up now at $2.61, with the move appearing sector-driven after positive Phase 3 melanoma vaccine results from Moderna and...
🟢 Connect Biopharma rises 5.3% — Biotech Sector Surges on Positive mRNA Cancer Vaccine Trial Results
With Biotech (XBI) up 3.7%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, proxied by the XBI ETF, is trading...
🟢 Connect Biopharma is trading 6.44% up in pre-market with no verified company-specific catalyst identified
Connect Biopharma is trading 6.44% up at $2.59 in pre-market, with no verified company-specific catalyst identified for August 19, 2026. - On August 12,...
🟢 Connect Biopharma is trading 6.69% up today in pre-market with no verified company-specific catalyst identified
Connect Biopharma is trading 6.69% up at $2.66 after no verified company-specific catalyst was identified for August 18, 2026. - The latest material...
🟢 Connect Biopharma is trading 6.43% up today in after-hours trading with no verified late-breaking catalyst identified
Connect Biopharma is trading at $2.65, up 6.43%, after no verified late-breaking catalyst was identified. - It closed at $2.49 on August 17, 2026; no new...
🟢 Connect Biopharma is trading 5.6% up in pre-market after completing Phase 2 enrollment
Connect Biopharma is trading 5.6% up in pre-market at $2.69 as investors continued reacting to its August 12 earnings update. - Completed enrollment in both...
🔴 Connect Biopharma is trading 5% down today after mixed second-quarter results and a widening net loss
Connect Biopharma is trading 5% down now at $2.41 after mixed second-quarter results and a widened net loss. - Collaboration revenue: $2.8 million, above...
🟢 Connect Biopharma is trading 10.3% up today after Q2 EPS beat
Connect Biopharma is trading 10.3% up at $2.57 after reporting second-quarter 2026 results on August 12, including $2.8 million in milestone revenue and an EPS...
🟢 Connect Biopharma is trading 6.01% up today after Q2 collaboration revenue from Simcere regulatory milestone
Connect Biopharma is trading 6.01% up now at $2.47 after reporting second-quarter results with $2.8 million in collaboration revenue, versus minimal...